MedPath

Intestinal Microbiota: Immunity, Recovery and Metabolic Health

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Whey protein hydrolysate milk product
Dietary Supplement: Placebo Comparator
Dietary Supplement: Postbiotic and whey protein hydrolysate milk product
Registration Number
NCT06355089
Lead Sponsor
University of Turku
Brief Summary

The aim of this intervention study is to investigate the effect of a specific postbiotic (Lacticaseibacillus rhamnosus GG = LGG) and whey protein on immunity, recovery, and weight management in young adults. The objective is based on previous knowledge about the health-promoting effects of these factors. A new goal is to study the combined effect of the postbiotic and whey protein. The results of the study can be utilized to promote the health of the young adults.

Detailed Description

The study is a randomized, double-blind, 3-arm intervention involving young adults (n=160). Participants are randomized into three groups to receive different study product, and differences among the groups will be compared, for example, in terms of gut microbiota, weight changes, and inflammatory markers derived from blood samples.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
160
Inclusion Criteria
  • healthy
Exclusion Criteria
  • medicines and diseases that significantly affect the functioning of the stomach and intestines (e.g. irritable bowel syndrome)
  • antibiotic treatment within 3 months
  • asthma medication
  • milk allergy (protein); the study product is lactose-free
  • the participant must adhere to avoid the use of foods or nutritional supplements containing probiotics, and high-protein products, e.g. whey protein powders and high-protein snack bars

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whey protein hydrolysate milk productWhey protein hydrolysate milk productUse of milk product with whey protein hydrolysate
Placebo milk productPlacebo ComparatorUse of low protein milk product
Postbiotic and whey protein hydrolysate milk productPostbiotic and whey protein hydrolysate milk productUse of milk product with whey protein hydrolysate and Lacticaseibacillus rhamnosus GG
Primary Outcome Measures
NameTimeMethod
Concentrations of inflammatory markers from the blood samplesAt the baseline (week 0) and after eight weeks (last visit)

hs-CRP (High-Sensitivity C-Reactive Protein), haptoglobin, suPAR (soluble urokinase-type Plasminogen Activator Receptor)

Secondary Outcome Measures
NameTimeMethod
Waist circumference of the participantAt the baseline (week 0) and after eight weeks (last visit)

Waist circumference

Changes in recoveryDuring intervention (Eight weeks)

Monitoring recovery using a sports watch.

Development of physical fitnessAt the baseline (week 0) and after eight weeks (last visit)

Based on walking test

Blood pressureAt the baseline (week 0), at four weeks and after eight weeks (last visit)

Blood pressure

Infections during the interventionDuring intervention (Eight weeks)

Self-reported infections during the intervention

Changes in the sleep qualityDuring intervention (Eight weeks)

Monitoring sleep quality using a sports watch.

Changes in the gut microbiota composition, diversity and functionAt the baseline (week 0) and after eight weeks (last visit)

Gut microbiota composition and function in feces by metagenomics shotgun sequencing

Weight of the participantAt the baseline (week 0), at four weeks and after eight weeks (last visit)

Weight

BMIAt the baseline (week 0), at four weeks and after eight weeks (last visit)

Body Mass Index (BMI)

Trial Locations

Locations (1)

University of Turku

šŸ‡«šŸ‡®

Turku, Finland

Ā© Copyright 2025. All Rights Reserved by MedPath